Journal of Clinical Endocrinology & Metabolism, Vol 76, 509-512, Copyright © 1993 by Endocrine Society

ARTICLES

A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D- resistant rickets

H Yagi, K Ozono, H Miyake, K Nagashima, T Kuroume and JW Pike
Department of Pediatrics, Gunma University School of Medicine, Japan.

Hereditary 1,25-dihydroxyvitamin D [1,25-(OH)2D]-resistant rickets (HVDRR) is a rare disorder characterized by rickets, alopecia, hypocalcemia, secondary hyperparathyroidism, and normal or elevated serum 1,25-dihydroxyvitamin D levels. We describe a patient with typical clinical characteristics of HVDRR, except that elevated levels of serum phosphorus were present coincident with increased levels of serum intact PTH. The patient was treated with high dose calcium infusion after an ineffective treatment with 1 alpha-hydroxyvitamin D3; serum calcium and phosphorus as well as intact PTH and alkaline phosphatase levels were normalized. Evaluation of phytohemagglutinin- activated lymphocytes derived from this patient revealed that 1,25- (OH)2D3 was unable to inhibit thymidine incooperation, a result that contrasts with the capacity of 1,25-(OH)2D3 to inhibit uptake into normal activated lymphocytes. 1,25-(OH)2D3 did not induce human osteocalcin promoter activity after transfection of this DNA linked to a reporter gene into patient cells. Cointroduction of a human vitamin D receptor (VDR) cDNA expression vector with the reporter plasmid, however, restored the hormone response. Evaluation of extracts from the patient cells for VDR DNA binding revealed a defect in DNA binding. Analysis of genomic DNA from the patient's cells by PCR confirmed the presence of a point mutation in exon 2 of the VDR. This exon directs synthesis of a portion of the DNA-binding domain of the receptor. We conclude that the genetic basis for 1,25-(OH)2D3 resistance in this kindred with VDR-positive HVDRR is due to a single base mutation in the VDR that leads to production of a receptor unable to interact appropriately with DNA.

This article has been cited by other articles:

				P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia Mol. Endocrinol., November 1, 2002; 16(11): 2538 - 2546. [Abstract] [Full Text] [PDF]

				P. J. Malloy, J. W. Pike, and D. Feldman The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets Endocr. Rev., April 1, 1999; 20(2): 156 - 188. [Abstract] [Full Text]

				H. T. Bruggenwirth, A. L. M. Boehmer, J. M. Lobaccaro, L. Chiche, C. Sultan, J. Trapman, and A. O. Brinkmann Substitution of Ala564 in the First Zinc Cluster of the Deoxyribonucleic Acid (DNA)-Binding Domain of the Androgen Receptor by Asp, Asn, or Leu Exerts Differential Effects on DNA Binding Endocrinology, January 1, 1998; 139(1): 103 - 110. [Abstract] [Full Text] [PDF]

				F. J. Cockerill, N. S. Hawa, N. Yousaf, M. Hewison, J. L H. O'Riordan, and S. M. Farrow Mutations in the Vitamin D Receptor Gene in Three Kindreds Associated with Hereditary Vitamin D Resistant Rickets J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3156 - 3160. [Abstract] [Full Text] [PDF]